SmithKline Beecham and Lek Agree to Extrajudicial Settlement
Ljubljana, 9 January - LEK/SMITHKLINE/BEECHAM
Pharmaceutical companies SmithKline Beecham from Great Britain and Lek of Ljubljana have reached an agreement on extrajudicial settlement of a dispute regarding Lek's alleged violation of SmithKline Beecham's intellectual property rights with production of the clavulanic acid, Lek announced on Friday.
The rest of this news item is available to subscribers.
The news item consists of 515 characters (without spaces) or 102 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.